Bevacizumab (Avastin®) for the management of anterior chamber neovascularization and neovascular glaucoma
Dimitrios Brouzas, Antonios Charakidas, Marilita Moschos, Chryssanthi Koutsandrea, Michael Apostolopoulos, Stefanos Baltatzis1st Department of Ophthalmology, University of Athens, Athens, GreecePurpose: To establish the efficacy and safety of intravitreal bevacizumab in reducing iris and anterior ch...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2009
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/b6c633c9407d42bd92ed654dde66ea31 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|